Family-owned Italian consumer health player Omega Pharma S.r.l. has sold a controlling stake for an undisclosed sum to private-equity firm 21 Invest.
Treviso-based 21 Invest is poised to acquire 65% of Omega, with chairman and CEO Gianantonio Tomaselli to retain a 35%...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?